These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34080517)

  • 41. Safe use of systemic bevacizumab for respiratory recurrent papillomatosis in two children.
    Carnevale C; Ferrán-De la Cierva L; Til-Pérez G; Peña-Zarza JA; Osona-Rodriguez B; Martinez-Lozano J; Sarría-Echegaray P; Arancibia-Tagle D; Tomás-Barberán M
    Laryngoscope; 2019 Apr; 129(4):1001-1004. PubMed ID: 30588638
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Current status of antiviral therapy for juvenile-onset recurrent respiratory papillomatosis.
    Kimberlin DW
    Antiviral Res; 2004 Sep; 63(3):141-51. PubMed ID: 15451182
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prolonged remission of juvenile-onset respiratory papillomatosis: a post-expositional role of the tetravalent anti-HPV vaccine?
    Yi L; Vaudaux B; Sandu K; Nisa L
    Int J Pediatr Otorhinolaryngol; 2014 Feb; 78(2):388-90. PubMed ID: 24388316
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cidofovir for the treatment of recurrent respiratory papillomatosis: a review of the literature.
    Shehab N; Sweet BV; Hogikyan ND
    Pharmacotherapy; 2005 Jul; 25(7):977-89. PubMed ID: 16006276
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Parenteral Bevacizumab for the Treatment of Severe Respiratory Papillomatosis in an Adult Population.
    Tkaczuk A; Trivedi S; Mody MD; Steuer CE; Shin DM; Klein AM; Saba NF
    Laryngoscope; 2021 Mar; 131(3):E921-E928. PubMed ID: 33107615
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Safety and Immunogenicity of a Nonadjuvant Human Papillomavirus Type 6 Virus-like Particle Vaccine in Recurrent Respiratory Papillomatosis.
    Zhang CQ; Yi S; Liu XJ; Nan BY; Huang SY; Chen BB
    J Voice; 2019 May; 33(3):363-369. PubMed ID: 30224308
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Airway Papillomatosis: New Treatments for an Old Challenge.
    Kumar N; Preciado D
    Front Pediatr; 2019; 7():383. PubMed ID: 31620412
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Spontaneous Regression of Recurrent Respiratory Papillomatosis with HPV Vaccination: A Case Study.
    Nyirjesy S; Osmundson P; Matrka L
    J Voice; 2022 Jul; 36(4):587.e21-587.e25. PubMed ID: 32891477
    [TBL] [Abstract][Full Text] [Related]  

  • 49. How Enhancing Immunity to Low-Risk HPV Could Cure Recurrent Respiratory Papillomatosis.
    Bai K; Allen C
    Laryngoscope; 2021 Sep; 131(9):2041-2047. PubMed ID: 33720393
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Systemic bevacizumab for end-stage juvenile recurrent respiratory papillomas: A case report.
    Hamdi O; Dome J; Zalzal G; Preciado D
    Int J Pediatr Otorhinolaryngol; 2020 Jan; 128():109706. PubMed ID: 31610441
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vocal cord surgery and pharmacological treatment of a patient with HPV and recurrent respiratory papillomatosis.
    Galletti F; Freni F; Gazia F; Gallo A
    BMJ Case Rep; 2019 Nov; 12(11):. PubMed ID: 31732543
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human papillomavirus types causing recurrent respiratory papillomatosis in Zimbabwe.
    Matinhira N; Soko ND; Bandason T; Jenson RG; Dzongodza T; von Buchwald C; Chidziva C
    Int J Pediatr Otorhinolaryngol; 2019 Jan; 116():147-152. PubMed ID: 30554686
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Systematic review of intralesional cidofovir dosing regimens in the treatment of recurrent respiratory papillomatosis.
    Clamp PJ; Saunders MW
    Int J Pediatr Otorhinolaryngol; 2013 Mar; 77(3):323-8. PubMed ID: 23369614
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bevacizumab as treatment option for recurrent respiratory papillomatosis: a systematic review.
    Pogoda L; Ziylan F; Smeeing DPJ; Dikkers FG; Rinkel RNPM
    Eur Arch Otorhinolaryngol; 2022 Sep; 279(9):4229-4240. PubMed ID: 35462578
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effectiveness of the human papillomavirus (types 6, 11, 16, and 18) vaccine in the treatment of children with recurrent respiratory papillomatosis.
    Hermann JS; Weckx LY; Monteiro Nürmberger J; Santos Junior GF; Campos Pignatari AC; Nagata Pignatari SS
    Int J Pediatr Otorhinolaryngol; 2016 Apr; 83():94-8. PubMed ID: 26968061
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of cidofovir versus bevacizumab in recurrent respiratory papillomatosis: A randomized, double-blind, placebo-controlled pilot study.
    Ablanedo-Terrazas Y; Estrada-Camacho O; Alvarado-de la Barrera C; Ramírez-García A; Tona-Acedo G; Bross-Soriano D; Schimelmitz-Idi J
    Acta Otorrinolaringol Esp (Engl Ed); 2021 Jun; ():. PubMed ID: 34154795
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recurrent respiratory papillomatosis: A 2020 perspective.
    Benedict JJ; Derkay CS
    Laryngoscope Investig Otolaryngol; 2021 Apr; 6(2):340-345. PubMed ID: 33869767
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Current diagnostic and management trends for recurrent respiratory papillomatosis.
    Silverman DA; Pitman MJ
    Curr Opin Otolaryngol Head Neck Surg; 2004 Dec; 12(6):532-7. PubMed ID: 15548913
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence and clinical implications of low-risk human papillomavirus among patients with recurrent respiratory papillomatosis in Rio de Janeiro, Brazil.
    Figueiredo MC; Justino MC; Delmonico L; Silvestre RT; de Castro TL; Dos Santos Moreira A; Macedo JMB; da Costa Carvalho MDG; Scherrer L; de Medeiros Lima DJM; Alves G; Ornellas MH
    Auris Nasus Larynx; 2019 Aug; 46(4):570-575. PubMed ID: 30581074
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recurrent respiratory papillomatosis of the airway: The experience of an endoscopic unit.
    Correia S; Dionísio J; da Costa JD
    Rev Port Pneumol (2006); 2015; 21(2):82-9. PubMed ID: 25926371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.